-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, KQ8Sp7Jip9Wc1qux2F1OeLB533TjhOdms4yzUtBaFtPsmo7l11FvtjA/xvaaKP41 RkgGweaDxfyLh72FDHUFPQ== 0001181431-04-019059.txt : 20040402 0001181431-04-019059.hdr.sgml : 20040402 20040402161701 ACCESSION NUMBER: 0001181431-04-019059 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20040331 FILED AS OF DATE: 20040402 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PSYCHIATRIC SOLUTIONS INC CENTRAL INDEX KEY: 0000829608 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 232491707 STATE OF INCORPORATION: DE FISCAL YEAR END: 0430 BUSINESS ADDRESS: STREET 1: 113 SEABOARD LANE STREET 2: SUITE C-100 CITY: FRANKLIN STATE: TN ZIP: 37067 BUSINESS PHONE: 615-312-5700 MAIL ADDRESS: STREET 1: 113 SEABOARD LANE STREET 2: SUITE C-100 CITY: FRANKLIN STATE: TN ZIP: 37067 FORMER COMPANY: FORMER CONFORMED NAME: PMR CORP DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: ZARON CAPITAL INC DATE OF NAME CHANGE: 19891116 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GRANT CHRISTOPHER JR CENTRAL INDEX KEY: 0001215553 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-20488 FILM NUMBER: 04714208 MAIL ADDRESS: STREET 1: C/O SALIX MANAGEMENT CORP. STREET 2: 30 BURTON HILLS BLVD, SUITE 370 CITY: NASHVILLE STATE: TN ZIP: 37215 4 1 rrd38493.xml FORM 4 DATED 03/31/2004 X0201 4 2004-03-31 0 0000829608 PSYCHIATRIC SOLUTIONS INC PSYS 0001215553 GRANT CHRISTOPHER JR C/O SALIX MANAGEMENT CORP. 30 BURTON HILLS BLVD., SUITE 370 NASHVILLE TN 37215 1 0 0 0 Common Stock 2004-03-31 4 C 0 364871 0 A 364871 I See Note Common Stock 2004-03-31 4 C 0 17291 0 A 17291 I See Note Common Stock 2004-03-31 4 J 0 364871 0 D 0 I See Note Common Stock 2004-03-31 4 J 0 17291 0 D 0 I See Note Common Stock 12594 D Common Stock 8261 I See Note Series A Convertible Preferred Stock 5.2333 2004-03-31 4 C 0 347183 0 D Common Stock 364871 0 I See Note Series A Convertible Preferred Stock 5.2333 2004-03-31 4 C 0 16453 0 D Common Stock 17291 0 I See Note Series A Convertible Preferred Stock 5.2898 Common Stock 360981 347183 I See Note Series A Convertible Preferred Stock 5.2898 Common Stock 17107 16453 I See Note Represents the number of shares issued to such Reporting Person upon conversion of shares of Series A Preferred Stock held by such Reporting Person as reported in Table II. The conversion price for these shares of Series A Preferred Stock was approximately $5.2333 per share. Each of these shares of Series A Preferred Stock was converted into approximately 1.05095 shares of Common Stock on March 31, 2004. Represents shares held by Salix Ventures II, L.P. Represents shares held by Salix Affiliates II, L.P. Represents shares held by CGJR Capital Management, Inc. The initial conversion price of the Series A Preferred Stock was $5.50, which has since been adjusted downward. As of March 31, 2004, each share of Series A Preferred Stock was convertible into approximately 1.03974 shares of Common Stock. The conversion price remains subject to further adjustment pursuant to the terms of the Series A Convertible Preferred Stock. Immediately after the conversion of the Series A Preferred Stock described in note (1), each of Salix Ventures II, L.P. and Salix Affiliates II, L.P., respectively, made an in-kind pro rata distribution of such shares of Common Stock to its general and limited partners (the "Primary Distributions"). Salix Partners II (the General Partner of both Salix Ventures II, L.P. and Salix Affiliates II, L.P.) in turn made an in-kind pro rata distribution of the shares of Common Stock it received in the Primary Distributions to its partners, including Christopher Grant, Jr. The conversion feature continues indefinitely. The Series A Preferred shares are immediately convertible. The securities are owned directly by Christopher Grant, Jr. and 1,194 shares of such total shares were received as part of the distribution described in note (6). In prior reports, Christopher Grant, Jr. reported indirect beneficial ownership of such 1,194 shares. Christopher Grant, Jr., a director of the Issuer, is the president and sole shareholder of CGJR Capital Management, Inc., and a general partner of Salix Partners II. Salix Partners II is the general partner of each of Salix Ventures II, L.P. and Salix Affiliates II, L.P. The Reporting Person disclaims beneficial ownership of any securities (except to the extent of his pecuniary interest in such securities) other than any securities reported herein as being directly owned by the Reporting Person, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of any such securities for purposes of Section 16 or for any other purpose. /s/ Robert D. Ivy, as attorney-in-fact for Christopher Grant, Jr. 2004-04-02 -----END PRIVACY-ENHANCED MESSAGE-----